Virtu Financial’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Virtu Financial’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,109	Closed	-$689K	–	2046
2019 Q3	$689K	Buy	+7,109	New	+$712K	0.05%	390
2018 Q4	–	Sell	-6,248	Closed	-$341K	–	2187
2018 Q3	$341K	Buy	6,248 +819	+15%	+$56K	0.02%	787
2018 Q2	$449K	Buy	+5,429	New	+$419K	0.03%	865
2018 Q1	–	Sell	-25,699	Closed	-$1.32M	–	2950
2017 Q4	$1.32M	Buy	25,699 +22,412	+682%	+$1.61M	0.07%	330
2017 Q3	$293K	Buy	+3,287	New	+$250K	0.01%	1409

Virtu Financial's ONCE Position: Q4 2019 in Review

Virtu Financial sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 7,109 shares — an estimated $689K sold.

Virtu Financial first reported a position in ONCE in Q3 2017 and held it in 5 quarters. The position peaked at $1.32M in Q4 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Virtu Financial reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Virtu Financial sold 7,109 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $689K.
Virtu Financial first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2017 and held it in 5 quarters.
Virtu Financial's Spark Therapeutics, Inc. Common Stock position peaked at $1.32M in Q4 2017.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.